Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety/Tolerability of Methylphenidate Transdermal System (MTS) for Before-School Dysfunction in Children With Attention Deficit Hyperactivity Disorder (ADHD)

NCT00586157 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT00586157
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00586157 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety/Tolerability of Methylphenidate Transdermal System (MTS) for Before-School Dysfunction in Children With Attention Deficit Hyperactivity Disorder (ADHD)
Lead sponsor
Massachusetts General Hospital
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2006
Completion date
December 31, 2008
Enrollment
36 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adhd, attention deficit hyperactivity disorder